Archive


Category: France

  • Germany says only Pfizer COVID jab should be used in under 30s

    Germany’s vaccination advisory committee has recommended that people aged under 30 should only be offered Pfizer/BioNTech’s COVID-19 vaccine Comirnaty, saying it seems less likely to cause heart inflammation than Moderna’s rival shot Spikevax. The draft guidance from the Robert Koch Institute’s STIKO committee also says that pregnant women, regardless of their age, should get the […]

  • France’s biotech ecosystem is primed for growth – it’s time to feed it

    After some years of stagnant funding and growth France is now at an inflection point for health care innovation, says Jeito Capital’s Dr Rafaèle Tordjman. Prior to the pandemic, our homegrown entrepreneurs felt too often they had to go abroad to the United States to get the funding they needed, government support for clinical trials […]

  • UK cancels Covid vaccine deal with French firm Valneva

    Government serves notice to terminate contract over allegations of a ‘breach of obligations’ Coronavirus – latest updates See all our coronavirus coverage The UK government is to pull out of a deal with the French pharmaceutical company Valneva to purchase its Covid-19 vaccination, the company has said. The move will come as a blow to […]

  • Sanofi scoops up Kadmon and its newly approved drug in a $1.9B deal

    The cash deal brings to Sanofi the Kadmon Holdings drug Rezurock, which the FDA approved in July as a treatment for chronic graft versus host disease. The French pharmaceutical giant will add Rezurock to a lineup of older products marketed globally for transplant procedures.

  • In Western Europe, hospitals look to quell the mental health epidemic among staff

    The Covid-19 pandemic pushed healthcare workers to their breaking point worldwide. In Western Europe, hospitals responded by offering free counseling and sharing videos on meditation and relaxation techniques, among other resources. But these efforts need to continue as it is likely the mental health epidemic will grow from here on out.

  • Vaccine wars: the week that rocked the UK’s Covid jab rollout

    After a week of bans, U-turns and warnings of supply shortfalls, public confidence in vaccination has been dented. Can Britain get back on the fast track out of lockdown? Coronavirus – latest updates See all our coronavirus coverage For Stacey Harris, the hardest part of organising vaccinations over the last couple of months has been […]

  • France limits AstraZeneca Covid jab to over-55s as Europe treads cautiously

    Three Scandinavian countries reserve judgment one day after EMA says shot is safe and effective Coronavirus – latest updates See all our coronavirus coverage France has said only people aged 55 and over should receive the AstraZeneca Covid-19 vaccine, and three Scandinavian countries have reserved judgment until next week, a day after Europe’s health regulator […]

  • France limits AstraZeneca Covid jab to over-55s as Europe treads cautiously

    Three Scandinavian countries reserve judgment one day after EMA says shot is safe and effective Coronavirus – latest updates See all our coronavirus coverage France has said only people aged 55 and over should receive the AstraZeneca Covid-19 vaccine, and three Scandinavian countries have reserved judgment until next week, a day after Europe’s health regulator […]

  • European countries to resume AstraZeneca jabs after safety backing

    EMA says benefits outweigh risks but it is continuing to study possible link with very rare blood clotting disorder Coronavirus – latest updates See all our coronavirus coverage Italy, France, Germany and several other countries will resume administering AstraZeneca jabs from Friday after Europe’s medicines regulator said the vaccine was “safe and effective” and its […]

  • European countries to resume AstraZeneca jabs after safety backing

    EMA says benefits outweigh risks but it is continuing to study possible link with very rare blood clotting disorder Coronavirus – latest updates See all our coronavirus coverage Italy, France, Germany and several other countries will resume administering AstraZeneca jabs from Friday after Europe’s medicines regulator said the vaccine was “safe and effective” and its […]

  • Benefits of Oxford/AstraZeneca vaccine outweigh any risk, says EMA

    European agency seeks to allay blood clot fears as Germany, France and Italy temporarily suspend use Coronavirus – latest updates See all our coronavirus coverage Europe’s medicines regulator has moved to stifle spiralling concern about the Oxford/AstraZeneca vaccine, saying the shot’s benefits outweigh the risks after four major EU countries announced they were suspending its […]

  • Germany backtracks on AZ COVID vaccine age restriction

    Germany has decided that AstraZeneca’s COVID-19 vaccine should be approved for use in the over-65s after all, reversing its earlier restriction in that age group.  The country’s drugs regulator previously limited use of the vaccine to the under-65s only, claiming that the data in the older age group was inadequate, even though the European Commission […]

  • Covid: Germany and France under pressure to shift Oxford vaccine

    Both countries urged to take action to avoid pile-up of unused AstraZeneca vaccine doses Coronavirus – latest updates See all our coronavirus coverage Authorities in Germany and France are under pressure to come up with creative solutions to shift the AstraZeneca vaccine at higher speed in order to avoid a pile-up of unused doses over […]

  • 2021 market access prospects for France

    In the latest of a suite of features looking at the biggest markets in Europe, Leela Barham takes stock of what 2021 could bring for market access in France. In September 2020, the French government published the draft of their annual review of spending on health and social care, which will form the basis of […]

  • AZ COVID jab efficacy debate is hindering EU’s vaccine drive

    The spat between the EU and AstraZeneca over access to the company’s COVID-19 shot led to scathing remarks about its efficacy that now threaten to undermine the EU’s vaccination targets.  The European Commission approved AZ’s AZD1222 vaccine for use in the EU in all adults aged over 18 at the end of January, more than […]

  • France and Germany threaten AstraZeneca over vaccine shortage

    Warning of ‘legal commitment’ and concern that doses might have been diverted from the EU to the UK Coronavirus – latest updates See all our coronavirus coverage France and Germany have threatened legal action against the Anglo-Swedish pharmaceutical company AstraZeneca in the row over a shortage of coronavirus vaccine in the EU. Talks between the […]

  • EU plans video summit after doubling supply of Pfizer Covid vaccine

    Bloc agrees deal for a further 300m doses as hopes are raised for speedier rate of inoculations Coronavirus – latest updates See all our coronavirus coverage EU leaders are to hold a pandemic video summit on 21 January after the bloc said it had reached a deal with Pfizer and BioNTech for 300m more doses […]

  • BioNTech criticises EU failure to order enough Covid vaccine

    Firm races to fill potential gap left by bloc’s gamble on several vaccines being approved Coronavirus – latest updates See all our coronavirus coverage BioNtech has criticised the EU’s failure to order more doses of its coronavirus vaccine, saying it is now racing with its US partner Pfizer to boost production amid fears of a […]

  • Ministers would be wise to play for time before ordering Sizewell C | Nils Pratley

    Dashing ahead with a nuclear power station that’s modelled on Hinkley Point C would be reckless This is the government’s problem as it reopens talks on a proposed nuclear power station at Sizewell C in Suffolk: it is contemplating ordering a replica of Hinkley Point C before the Somerset original has produced a single megawatt […]

  • French startup lands $8.7M to advance microbiome therapies

    Founded in 2014, MaaT Pharma is pushing two therapies through clinical trials that are designed improve survival for patients with blood cancers and other diseases. Despite high-profile hiccups, the field of microbiome therapy remains attractive to investors.

  • GSK and Sanofi to start human trials of potential Covid-19 vaccine

    World’s largest vaccine makers to begin testing on people in US with eye on rollout in early 2021 Coronavirus – latest updates See all our coronavirus coverage GlaxoSmithKline and Sanofi are to start testing their protein-based Covid-19 vaccine on humans for the first time, following promising results in earlier studies. GSK, the world’s largest vaccine […]

  • How does HTA for orphan drugs differ across europe?

    New research looks at the factors that speed up and slow down HTA appraisals for rare disease medicines across Europe. Rare diseases drugs have always faced challenges when it comes to HTA approvals, even as governments bring in more regulatory policies that make their path through assessment easier. Several factors make it difficult for HTA […]